Mizuho Securities Upgrades Acadia Pharmaceuticals (ACAD) to Buy, 'Strengthening Fundamentals'
Tweet Send to a Friend
(Updated - November 6, 2023 7:03 AM EST)
Mizuho Securities analyst Uy Ear upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Uy Ear upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
